Table 2 Serological and virological data of ZIKV- and DENV-infected patients.
Patient ID (Gender) | Days after symptoms onset | Sample | ZIKV Real Time RT-PCRa | DENV Real Time RT-PCRb | CHIKV Real Time RT-PCRc | Anti ZIKV IgGd | Anti ZIKV IgMd | Anti DENV IgGd | Anti DENV IgMd | Anti CHIKV IgGd | Anti CHIV IgMd |
|---|---|---|---|---|---|---|---|---|---|---|---|
Pt1 (F) | 3 | Serum | Negative | Negative | Negative | 1:320 | <1:20 | 1:640 | <1:20 | <1:20 | <1:20 |
Urine | Positive | Negative | ND | ND | ND | ND | ND | ND | ND | ||
Saliva | Positive | Negative | ND | ND | ND | ND | ND | ND | ND | ||
Pt2 (F) | 2 | Serum | Positive | Negative | Negative | <1:20 | <1:20 | <1:20 | <1:20 | <1:20 | <1:20 |
Urine | Positive | Negative | ND | ND | ND | ND | ND | ND | ND | ||
Saliva | Negative | Negative | ND | ND | ND | ND | ND | ND | ND | ||
Pt3e (F) | 9 | Serum | Negative | Negative | Negative | 1:160 | 1:80 | 1:40 | <1:20 | <1:20 | <1:20 |
Urine | Positive | Negative | ND | ND | ND | ND | ND | ND | ND | ||
Pt4 (M) | 9 | Serum | Negative | Negative | Negative | 1:80 | 1:160 | 1:20 | <1:20 | <1:20 | <1:20 |
Urine | Positive | Negative | ND | ND | ND | ND | ND | ND | ND | ||
Saliva | Negative | Negative | ND | ND | ND | ND | ND | ND | ND | ||
Pt5 (F) | 9 | Serum | Positive | Negative | Negative | 1:160 | 1:80 | 1:160 | <1:20 | <1:20 | <1:20 |
Urine | Positive | Negative | ND | ND | ND | ND | ND | ND | ND | ||
Saliva | Negative | Negative | ND | ND | ND | ND | ND | ND | ND | ||
Pt6 (F) | 6 | Serum | Negative | Negative | Negative | 1:20 | 1:80 | <1:20 | <1:20 | <1:20 | <1:20 |
Urine | Positive | Negative | ND | ND | ND | ND | ND | ND | ND | ||
Saliva | Negative | Negative | ND | ND | ND | ND | ND | ND | ND | ||
Pt7 (F) | 9 | Serum | Negative | Negative | Negative | 1:160 | 1:80 | <1:20 | <1:20 | <1:20 | <1:20 |
Urine | Positive | Negative | ND | ND | ND | ND | ND | ND | ND | ||
Saliva | Negative | Negative | ND | ND | ND | ND | ND | ND | ND | ||
Pt8 (M) | 9 | Serum | Negative | Positive | Negative | <1:20 | <1:20 | Weak reactivity | 1:40 | <1:20 | <1:20 |
Urine | Negative | Positive | ND | ND | ND | ND | ND | ND | ND | ||
Saliva | Negative | Negative | ND | ND | ND | ND | ND | ND | ND | ||
Pt9 (M) | 4 | Serum | Negative | Positive | Negative | <1:20 | <1:20 | <1:20 | <1:20 | <1:20 | <1:20 |
Urine | Negative | Negative | ND | ND | ND | ND | ND | ND | ND | ||
Saliva | Negative | Negative | ND | ND | ND | ND | ND | ND | ND | ||
Pt10 (M) | 5 | Serum | Negative | Positive | Negative | <1:20 | 1:40 | 1:40 | 1:80 | <1:20 | <1:20 |
Urine | Negative | Positive | ND | ND | ND | ND | ND | ND | ND | ||
Saliva | Negative | Negative | ND | ND | ND | ND | ND | ND | ND | ||
Pt11 (F) | 5 | Serum | Negative | Positive | Negative | <1:20 | <1:20 | <1:20 | Weak reactivity | <1:20 | <1:20 |
Urine | Negative | Positive | ND | ND | ND | ND | ND | ND | ND | ||
Saliva | Negative | Positive | ND | ND | ND | ND | ND | ND | ND | ||
Pt12 (F) | 4 | Serum | Negative | Positive | Negative | <1:20 | <1:20 | 1:40 | <1:20 | <1:20 | <1:20 |
Urine | Negative | Negative | ND | ND | ND | ND | ND | ND | ND | ||
Saliva | Negative | Negative | ND | ND | ND | ND | ND | ND | ND |